Pharma Villain Martin Shkreli Takes the Heat Off Other Drug Companies

Medical entrepreneur Martin Shkreli was vilified when he increased the price of a drug fiftyfold overnight. And just as swiftly, cheers broke out across the internet when he was arrested last week on securities fraud charges.

But one reporter says, in some ways, Shkreli's arrest has "taken the heat off other drug companies."

Andy Pollack, New York Times reporter covering business and science of biotechnology, discusses how infamous price gouger Martin Shkreli has obscured similar practices by other drug companies by becoming the face of inflated drug prices.